People: Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

93.40USD
1 May 2015
Change (% chg)

$1.16 (+1.26%)
Prev Close
$92.24
Open
$92.81
Day's High
$93.45
Day's Low
$92.49
Volume
252,988
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

Summary

Name Age Since Current Position

Kevin Lobo

49 2014 Chairman of the Board, President, Chief Executive Officer

William Jellison

57 2013 Chief Financial Officer, Vice President

Lonny Carpenter

53 2009 Group President - Global Quality and Operations

David Floyd

54 2012 Group President - Orthopaedics

Timothy Scannell

50 2013 Group President - MedSurg and Neurotechnology

Ramesh Subrahmanian

53 2011 Group President - International

William Berry

49 2014 Principal Accounting Officer, Vice President, Corporate Controller

Bijoy Sagar

46 2014 Chief Information Officer, Vice President

Scott Bruder

51 2013 Vice President, Chief Medical and Scientific Officer

Steven Benscoter

47 2012 Vice President - Human Resources

Katherine Owen

44 2007 Vice President - Strategy and Investor Relations

Dean Bergy

55 2013 Vice President, Corporate Secretary

Bronwen Taylor

2013 Vice President - Compliance and Risk Management

Michael Hutchinson

44 2014 General Counsel

Curtis Hall

57 2013 Chief Legal Officer

William Parfet

68 2014 Lead Independent Director

Howard Cox

72 1974 Independent Director

Srikant Datar

62 2009 Independent Director

Roch Doliveux

58 2010 Independent Director

Louise Francesconi

61 2006 Independent Director

Allan Golston

48 2011 Independent Director

Andrew Silvernail

44 2013 Independent Director

Ronda Stryker

49 1984 Independent Director

Biographies

Name Description

Kevin Lobo

Mr. Kevin A. Lobo has been appointed as Chairman of the Board, President, Chief Executive Officer of Stryker Corporation, effective July 22, 2014. He joined the Company as a Group President in April 2011. Prior thereto, he held several senior leadership roles over eight years with Johnson & Johnson, including serving as worldwide president of Ethicon Endo-Surgery and president of J&J’s Medical Products business in Canada. Mr. Lobo is also a director of Parker-Hannifin Corporation, a manufacturer of motion and control technologies and systems. Mr. Lobo’s more than 25 years of global business and leadership experience across multiple industries, including healthcare, enables him to provide valuable insight to the Board regarding the Company’s operations and the strategic planning initiatives necessary to meet the demands of the changing environment. As the sole member of management on our Board, he provides management’s business perspectives and the necessary link to the day-to-day operations.

William Jellison

Mr. William R. Jellison has been appointed as Chief Financial Officer, Vice President of Stryker Corporation, effective April 22, 2013. He has been employed by Dentsply International Inc., a manufacturer of dental and other consumable medical device products, for the past 15 years, most recently as Senior Vice President and Chief Financial Officer since January 2005, a position he also held from April 1998 until November 2002. From November 2002 until January 2005, Mr. Jellison served as a Senior Vice President of Dentsply, with domestic and international operating responsibilities. Prior to April 1998, Mr. Jellison held various financial management positions, including Vice President of Finance, Treasurer and Corporate Controller, for Donnelly Corporation, an international automotive parts supplier, since 1980. Mr. Jellison graduated from Hope College with a bachelor's degree in business administration, became a Certified Management Accountant and is a member of both the IMA and FEI.

Lonny Carpenter

Mr. Lonny J. Carpenter is Group President - Global Quality and Operations of Stryker Corporation, since September 1, 2009. He was the Group President, Instruments and Medical since November 2008. He had previously been President, Stryker Medical since May 2008 and Vice President and General Manager, Stryker Medical since 2006. After joining the Company in 1989, Mr. Carpenter held various roles of increasing responsibility at Stryker Instruments before being promoted to Vice President, Global Operations, Stryker Instruments in 2004.

David Floyd

Mr. David K. Floyd has been appointed as Group President, Orthopaedics of Stryker Corporation, effective November 15, 2012. Mr. Floyd joins Stryker after 25 years in the medical technology and orthopaedics industry where he held a number of senior level leadership roles at DePuy, a division of Johnson and Johnson, Abbott Spine, AxioMed Spine, Centerpulse Orthopaedics and most recently as Chief Executive Officer for OrthoWorx.

Timothy Scannell

Mr. Timothy J. Scannell is Group President - MedSurg and Neurotechnology of Stryker Corporation, since September 1, 2009. He was Group President, Spine and Endoscopy since November 2008. He had previously been President, Stryker Spine since 2005 and Vice President and General Manager, Stryker Spine since 2003. After joining the Company in 1990, Mr. Scannell is leadership roles at Stryker Endoscopy before being promoted to Vice President and General Manager, Stryker Biotech in 2001.

Ramesh Subrahmanian

Mr. Ramesh Subrahmanian is Group President - International of Stryker Corporation, since September 1, 2011. He joins Stryker after twenty-three years in the pharmaceutical industry where he held a number of senior level leadership roles at Merck, Sanofi-Aventis and Hoechst Marion Roussel Ltd., most recently as Senior Vice President & President, Asia Pacific for Merck & Co. Inc. In his new role, he will have responsibilities for the Company's international business units and will be based in Singapore.

William Berry

Mr. William E. Berry, Jr., serves as Principal Accounting Officer, Vice President, Corporate Controller of Stryker Corporation, since 2014.

Bijoy Sagar

Mr. Bijoy S.N. Sagar serves as Chief Information Officer, Vice President of Stryker Corporation, since 2014.

Scott Bruder

Dr. Scott P. Bruder, MD, PhD is Vice President, Chief Medical and Scientific Officer of Stryker Corp. Dr. Bruder is responsible for overseeing Stryker's medical and scientific efforts, including academic, industrial and governmental scientific partnerships. Dr. Bruder joined Stryker after a long and proven history of performance across multiple roles in his career, where he held a number of senior executive and scientific roles at DePuy, a division of Johnson and Johnson, Anika Therapeutics, and Osiris Therapeutics, and most recently, Chief Science and Technology Officer for Becton, Dickinson and Company. Dr. Bruder is also an accomplished researcher and innovator with more than 20 issued and pending U.S. and international patents. He has published nearly 150 original articles, book chapters and abstracts in peer-reviewed journals, and received numerous awards from the American Academy of Orthopaedic Surgeons, the Orthopaedic Research Society and the Association of Bone and Joint Surgeons. Dr. Bruder graduated from Brown University and Case Western Reserve University School of Medicine, with a PhD in stem cell biology. He also obtained additional surgical training at the University of Pennsylvania. He maintains an active academic presence at CWRU as an adjunct professor of biomedical engineering, where he was previously an adjunct faculty member in the Department of Orthopaedic Surgery.

Steven Benscoter

Mr. Steven P. Benscoter has been appointed as Vice President, Human Resources of Stryker Corporation, effective 2012.

Katherine Owen

Ms. Katherine Ann Owen is Vice President - Strategy and Investor Relations of Stryker Corporation, since February 15, 2007. Prior to joining the Company, she served as a medical technology analyst at Merrill Lynch. Prior to that she held a similar position at Cowen & Co./SG Cowen and had been a corporate lending analyst at State Street Bank.

Dean Bergy

Mr. Dean H. Bergy is Vice President, Corporate Secretary of Stryker Corporation. He is no longer Interim Chief Financial Officer of the company effective April 22, 2013. He had previously been Vice President, Chief Financial Officer from January 2003 to March 2009, has been appointed Interim Chief Financial Officer effective October 1, 2012. Following his resignation as Vice President, Chief Financial Officer, Mr. Bergy continued to be employed by the Company as an Advisor to the CFO and was elected Secretary of the Company in September 2011 and Vice President, Corporate Secretary in September 2012.

Bronwen Taylor

Ms. Bronwen R. Taylor is Vice President - Compliance and Risk Management of Stryker Corp. She subsequently served as Vice President and Chief Financial Officer and as Director, Operations, of Stryker South Pacific. Ms. Taylor relocated to Kalamazoo in January 2006 to become Stryker's first Chief Compliance Officer. In 2007 Ms. Taylor was promoted to Vice President of Internal Audit and Compliance and in 2010 she moved to Newbury, UK to become Vice President, Chief Financial Officer for European operations. Prior to joining Stryker, Ms. Taylor held senior finance positions in financial services and global mining companies in Australia. She started her career as an accountant with Coopers & Lybrand (now PricewaterhouseCoopers) in Australia and held various positions in the Australian and United Kingdom firms. Ms. Taylor holds a B.B.A. from the Queensland University of Technology, Australia, and an M.B.A. from Monash University, Victoria, Australia. She is also a fellow of the Institute of Chartered Accountants in Australia.

Michael Hutchinson

Mr. Michael D. Hutchinson serve as General Counsel of Stryker Corporation, since 2014.

Curtis Hall

Mr. Curtis E. Hall, Esq., is Chief Legal Officer of Stryker Corp. He was Vice President and General Counsel and Secretary of the Company. He had previously been General Counsel for the Company since 1994. Prior to joining the Company, he was a partner in the Michigan law firm of Miller, Canfield, Paddock and Stone, an Assistant United States Attorney in Washington, D.C. and an Assistant District Attorney in New York City.

William Parfet

Mr. William U. Parfet is Lead Independent Director of Stryker Corp. Mr. Parfet has served as Chairman and Chief Executive Officer of MPI Research, Inc., a global preclinical research organization, since 1999. He is also a director of Monsanto Company, a provider of agricultural products that improve farm productivity, and Taubman Centers, Inc., a real estate development company. From 1993 to 1996, Mr. Parfet served as the president and CEO of Richard-Allan Medical, a worldwide manufacturer of surgical products. Prior to that, he had a 30-year career with the Upjohn Company (now part of Pfizer) as both an executive and member of the Board of Directors. He also previously served as a trustee of the Financial Accounting Foundation, the group that oversees the Financial Accounting Standards Board. Mr. Parfet has extensive experience in executive leadership roles, in serving as a director on the boards of a number of public companies and a long tenure on the Stryker Board, giving him a deep understanding of the role of the Board of Directors and positioning him well to serve as our Lead Independent Director.

Howard Cox

Mr. Howard E. Cox, Jr., is Independent Director of Stryker Corp., since 1974. He is Partner of Greylock and its affiliated venture capital partnerships since 1971. He is also a Director Secretary of Defense Business Board, a member of the Harvard Medical School Board of Fellows and of the Investment Committees of the Dana Farber Cancer Institute, Partners Healthcare System, Inc. and the Boston Museum of Fine Arts. Mr. Cox has a broad and deep level of experience as a board member, having served on over 30 boards of directors, including many that were public companies and a number of which were in the healthcare industry. His extensive experience in the venture capital business has given him valuable insight in assessing overall business risks, particularly related to acquisitions. Having served on the Stryker Board for 40 years, he brings a valuable historical context to our Board.

Srikant Datar

Dr. Srikant M. Datar, Ph.D., is Independent Director of Stryker Corp., since July 29, 2009. He serves at Arthur Lowes Dickinson Professor at the Graduate School of Business Administration of Harvard University since 1996 and Senior Associate Dean from 2001 to 2010. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. He is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and T-Mobile US, Inc., a provider of wireless voice, messaging and data services. Dr. Datar has an extensive background in accounting and finance and a variety of other business areas, including organization design and performance measurement. His strong accounting and finance background and his experience as chair of the Audit Committee at Novartis AG and T-Mobile US, Inc. allow him to make significant contributions on our Audit Committee. His service on the boards of global companies involved in pharmaceuticals and high tech gives him great insights on assessing Stryker’s technology and strategies to expand our business globally.

Roch Doliveux

Dr. Roch Doliveux, DVM, is Independent Director of Stryker Corp., since June 21, 2010. He served as Chief Executive Officer and Chairman of the Executive Committee of UCB S.A., a global biopharmaceutical company, from 2005 through 2014. Prior thereto, he was Chief Executive Officer of Pierre Fabre Pharmaceuticals and President of Schering-Plough International, a subsidiary of Schering-Plough Corporation. Dr. Doliveux has extensive experience in life science and healthcare companies, including product management, global marketing, research and development, and strategic and organizational change management. His exposure to business in many geographies and cultures is very valuable as Stryker seeks to expand its global presence.

Louise Francesconi

Ms. Louise L. Francesconi is Independent Director of Stryker Corp., since July 26, 2006. Former Vice President of Raytheon Company and former President of Raytheon Missile Systems, which she led from 1996 to July 2008. She is Chairman of the Tucson Medical Center Healthcare Board of Trustees and a director of UNS Energy Corporation, a utility that delivers natural gas and electric service. Ms. Francesconi’s extensive experience in various leadership roles in operations and finance functions at Raytheon and other major businesses for over 30 years enable her to bring a wealth of insight into the complex operational, financial and governance issues facing the Company. Her role as Chairman of the Tucson Medical Center Board also has provided useful insights from the perspective of a healthcare provider.

Allan Golston

Mr. Allan C. Golston is Independent Director of Stryker Corp., since January 1, 2011. President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston has extensive experience in auditing, finance and the healthcare industry. He is a Certified Public Accountant and has held positions as a finance executive with Swedish Health Services (Seattle, WA) and the University of Colorado Hospital. In his service to the Gates Foundation, he has contributed to the strategic formation and operation of successful initiatives to provide healthcare, education and other human needs, all of which give him understanding that will assist Stryker in our global efforts to meet the needs of patients and caregivers. Additionally, Mr. Golston’s expertise and experience in financial matters enable him to make valuable contributions to our Audit Committee.

Andrew Silvernail

Mr. Andrew K. Silvernail is Independent Director of the company. he is Chairman, President and Chief Executive Officer of IDEX Corporation, Chairman since 2012 and President and Chief Executive Officer since 2011, and Vice President, Group Executive from January 2009 to August 2011. Mr. Silvernail is also a trustee for the Manufacturers Alliance for Productivity and Innovation (MAPI). By virtue of service as Chairman, President and Chief Executive Officer of IDEX Corporation and his prior experience in executive leadership positions with IDEX and another large public company, Mr. Silvernail provides valuable business, leadership and management insights and useful perspectives to our Board discussions. His experience leading a large public company with global operations gives him a clear understanding of the issues facing a multinational business such as ours.

Ronda Stryker

Ms. Ronda E. Stryker is Independent Director of Stryker Corp., since 1984. She is also Vice Chair and a director of Greenleaf Trust, a Michigan chartered bank, Vice Chair of Spelman College, a trustee of Kalamazoo College and member of the Harvard Medical School Board of Fellows. Ms. Stryker brings a strong interest in advocating the benefits of diversity and various matters regarding social responsibility. As the Company’s largest individual shareholder and a member of the founding family, she brings a strong shareholder perspective, unlike that of any other member of our Board, making her a valuable component of a well-rounded Board.
Search Stocks